Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1157-2026

SQ40S Blood Transfusion Filter Recall

SQ40S Blood Transfusion Filter

FDA recall Class II

Ongoing

FDA lists this Class II recall for SQ40S Blood Transfusion Filter. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1157-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Nov 3, 2025
FDA report date
Jan 28, 2026
Quantity in commerce
2,720 filters
Distribution
See key details
FDA cause
Process control

What is being recalled?

SQ40S Blood Transfusion Filter

Affected model & UDI checker

Search the exact identifiers published for Z-1157-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedSQ40S Blood Transfusion FilterCheck source notice10887691000666
FDA code information

Product Number: SQ40S UDI-DI code: 10887691000666 Lot Number: 7536142

View the original FDA recall notice

Why was this product recalled?

Due to products being released for distribution prior to completion of the required quality control release process the sterility assurance cannot be confirmed.

What actions did GVS TM, Inc take?

On 11/03/2025, the firm sent via email a "GVS TM Inc Customer Statement" informing customers that GVS TM Inc discovered that some of the products in the affected lot may have been damaged during the transportation process. To avoid any potential risk this damage may pose to the downstream user, the firm is requesting return of the affected products. On 11/18/2025, the firm sent via email a "GVS TM Inc Product Recall Statements" informing customers that the products were distributed before completion of the required quality control release process, including final review of sterilization documentation and Certificate of Analysis. As a result the sterility assurance cannot be confirmed. Customers are instructed to: 1) Return all units of Lot 7536142 to GVS TM Inc - Customer Service using GVS TM FedEx Account 203742698, or 2) Destroy the affected units at their facility according to their internal disposal procedures for medical devices. 3) Confirmation Required - If Returning Product --Quantity returned --Date Shipped Back --Contact Person - If Destroying Product (Proof of Destruction Required) --Signed destruction confirmation --Statement on facility letterhead indicating: ---Quantity destroyed ---Date of Destruction ---Method of disposal ---Name/title of the person performing destruction Upon receipt of the above information, GVS TM Inc will issue replacements or credit depending on customer's preference. Questions - Contact GVS TM Customer Service at customerservice tm.na@gvs.com

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology